Purchases and Sales Made in Q2 2025 in Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS) during Q2 2025. The information is specifically focused on institutions that hold shares of Corvus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 22, 2025
Q2 2025
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
319KNew |
$899K - $1.43M
|
319K
$1.43M
|
|
|
Jul 21, 2025
Q2 2025
|
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
|
BUY
|
- |
168KNew |
$474K - $756K
|
168K
$756K
|
|
|
Jul 14, 2025
Q2 2025
|
Masso Torrence Wealth Management Inc.
|
BUY
|
- |
15K+ 42.86% |
$42.3K - $67.5K
|
50K
$225K
|
|
|
Jul 21, 2025
Q2 2025
|
Mirae Asset Global Investments Co., Ltd.
|
BUY
|
- |
931+ 45.46% |
$2.63K - $4.19K
|
2.98K
$13.4K
|